Company
Every investor coverage indicates participated in a round Opuz raised.
Companies Opuz acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Andrew Just | CEO | Wholesale Investor |
Stories naming Opuz. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Company profile and investment offering for Opuz, which is developing a non-invasive wearable ring for blood glucose monitoring, highlighting a successful clinical study and plans for a 2022 launch.